Ratnakar Securities Pvt. Ltd.

FISCHER MEDICAL VENTURES LTD.

NSE : FISCHERBSE : 524743ISIN CODE : INE771F01041Industry : ChemicalsHouse : Private

BSE46.29-0.48 (-1.03 %)

PREV CLOSE ( ) 46.77

OPEN PRICE ( ) 47.01

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 72713

TODAY'S LOW / HIGH ( )45.86 47.11

52 WK LOW / HIGH ( )40.95 124.2

Select year

Particulars	Mar2025	Mar2024	Mar2023
Operational & Financial Ratios
Earnings Per Share (Rs)	0.23	0.26	-2.12
CEPS(Rs)	0.04	0.04	-0.21
DPS(Rs)	0.05	0.00	0.00
Book NAV/Share(Rs)	48.17	15.00	-15.47
Tax Rate(%)	45.66	12.95	-2707.69
Margin Ratios
Core EBITDA Margin(%)	3.02	8.86	8.47
EBIT Margin(%)	2.45	10.38	8.47
Pre Tax Margin(%)	2.01	10.06	-0.72
PAT Margin (%)	1.09	8.76	-20.33
Cash Profit Margin (%)	2.57	9.63	-20.33
Performance Ratios
ROA(%)	0.44	4.25	-14.72
ROE(%)	0.62	4.60	0.00
ROCE(%)	1.13	5.35	4.97
Asset Turnover(x)	0.41	0.48	0.72
Sales/Fixed Asset(x)	5.19	1.32
Working Capital/Sales(x)	0.42	0.32	0.90
Efficiency Ratios
Fixed Capital/Sales(x)	0.19	0.76	0.00
Receivable days	163.11	200.41	346.90
Inventory Days	22.49	77.86	0.00
Payable days	45.45	24.06
Valuation Parameters
PER(x)	386.61	242.45	0.00
PCE(x)	2016.21	1654.39	-39.58
Price/Book(x)	18.64	41.65	-5.43
Yield(%)	0.01	0.00	0.00
EV/Net Sales(x)	50.01	157.47	11.03
EV/Core EBITDA(x)	1144.95	1399.44	130.31
EV/EBIT(x)	2038.25	1516.40	130.31
EV/CE(x)	13.91	40.73	6.48
M Cap / Sales	51.74	159.28	8.05
Growth Ratio
Net Sales Growth(%)	427.61	0.00	0.00
Core EBITDA Growth(%)	104.82	0.00	0.00
EBIT Growth(%)	24.67	0.00	0.00
PAT Growth(%)	-34.28	5135.34	0.00
EPS Growth(%)	-9.88	112.14	0.00
Financial Stability Ratios
Total Debt/Equity(x)	0.20	0.00	-2.15
Current Ratio(x)	3.59	18.37	5.18
Quick Ratio(x)	3.50	17.21	5.18
Interest Cover(x)	5.50	32.23	0.92
Total Debt/Mcap(x)	0.01	0.00	0.40

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Financial Ratios

FISCHER MEDICAL VENTURES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES